Loss of the ATM gene or kinase inhibition of ATM promotes proteasomal degradation of the CBP protein and breakage of DOT1L-H3K79me signalling, ultimately leading to exhaustion of MLLr-AML cells. This evidence concerns the gene CREBBP and acute myeloid leukemia.